StottsN, AraiS, et al.: Predictors of thirst in intensive care unit patients. J Pain Symptom Manage, 2015; 49:530–538.
2.
WiffenP, DerryS, MooreR: Impact of morphine, fentanyl, oxycodone, or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev, 2015; 5:CD011056.
3.
WelchJ: Development of the thirst distress scale. Nephrol Nurs J, 2002; 29:337–341.
4.
EllershawJ, SutcliffJ, SaundersC: Dehydration and the dying patient. J Pain Sympt Manag, 1995; 10:192–197.
5.
MoritaT, TeiY, et al.: Determinants of the sensation of thirst in terminally ill cancer patients. Suppt Care Cancer, 2001; 9:177–186.
6.
BurgeF: Dehydration symptoms of palliative care cancer patients. J Pain Sympt Manag, 1993; 8:454–464.
7.
MusgraveC, BartalN, OpstadJ: The sensation of thirst in dying patients receiving IV hydration. J Palliat Care, 1995; 11:17–21.
8.
CerchiettiL, NaviganteA, et al.: Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs, 2000; 6:370–374.
9.
McCannR, HallW, Groth-JunckerA: Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA, 1994; 272:1263–1266.
10.
BotsC, BrandH, et al.: Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int, 2004; 66:1662–1668.
11.
MistianP: Thirst, interdialytic weight gain and thirst-interventions in hemodialysis patients: A literature review. Nephrol Nurs J, 2001; 28:601–615.
12.
KooistraM, VosJ, et al.: Daily home haemodialysis in the Netherlands: Effects on metabolic control haemodynamics, and quality of life. Nephrol Dial Transplant, 1998; 13:2853–2860.
13.
YamamotoT, ShimizuM, et al.: Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure. JAMA, 1986; 256:604–608.
14.
OldenburgB, MacDonaldG, ShelleyS: Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis. BMJ, 1988; 296:1089–1091.
15.
KuriyamaS, TomonariH, SakaiO: Effect of cilazapril on hyperdipsia in hemodialyzed patients. Blood Purif, 1996; 14:35–41.
16.
HamadA, KhosrovanehA, et al.: Lack of effect of long-term use of angiotensin-converting enzyme inhibitors by hemodialysis patients on thirst and fluid weight gain. Ren Fail, 2002; 24:461–466.
17.
BotsC, BrandH, et al.: Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis. Nephrol Dial Transplant, 2005; 20:578–584.
18.
JagodzińskaM, Zimmer-NowickaJ, et al.: Three months of regular gum chewing neither alleviates xerostomia nor reduces overhydration in chronic hemodialysis patients. J Ren Nutr, 2011; 21:410–417.
19.
PuntilloK, AraiS, et al.: Symptoms experienced by intensive care unit patients at high risk of dying. Crit Care Med, 2010; 38:2155–2160.
20.
PuntilloK, AraiS, et al.: A randomized clinical trial of an intervention to relieve thirst and dry mouth in intensive care unit patients. Intensive Care Med, 2014; 40:1295–1302.
21.
HolstM, StrombergA, et al.: Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: Result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity. Scand Cardiovasc J, 2008; 42:316–322.
22.
AlitiG, RabeloE, et al.: Aggressive fluid and sodium restriction in acute decompensated heart failure: A randomized clinical trial. JAMA Intern Med, 2013; 173:1058–1064.
23.
LiY, FuB, QianX: Liberal versus restricted fluid administration in heart failure patients: A systematic review and meta-analysis of randomized trials. Int Heart J, 2015; 56:192–195.
